Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study
| Autor: | Roux, C., Hofbauer, L.C., Ho, P.R., Wark, J.D., Zillikens, M.C., Fahrleitner-Pammer, A., Hawkins, F., Micaelo, M., Minisola, S., Papaioannou, N., Stone, M., Ferreira, I., Siddhanti, S., Wagman, R.B., Brown, J.P. |
|---|---|
| Zdroj: | In Bone January 2014 58:48-54 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect